Interleukin 18 binding protein (IL18-BP) inhibits neointimal hyperplasia after balloon injury in an atherosclerotic rabbit model

Journal of Vascular Surgery

Volumn 47, Issue 5, 2008, Pages 1048-1057

  Li, Jian Ming ^a   Eslami, Mohammad H ^a   Rohrer, Michael J ^a   Dargon, Phong ^a   Joris, Isabella ^a   Hendricks, Gregory ^a   Baker, Stephen ^a   Cutler, Bruce S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 18 BINDING PROTEIN; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RECOMBINANT CYTOKINE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG DOSE COMPARISON; EMBOLECTOMY; ENDOTHELIUM CELL; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; INFLAMMATORY CELL; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIPID DIET; LIPID STORAGE; LIVER FUNCTION; MACROPHAGE; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; SUPERFICIAL FEMORAL ARTERY; THORACIC AORTA; TRANSMISSION ELECTRON MICROSCOPY;

ANGIOPLASTY, BALLOON; ANIMALS; ATHEROSCLEROSIS; DIETARY FATS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMORAL ARTERY; HYPERPLASIA; INFLAMMATION; INJECTIONS, INTRAVENOUS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY FUNCTION TESTS; LIPID METABOLISM; LIPIDS; LIVER FUNCTION TESTS; MALE; MICE; RABBITS; RECOMBINANT PROTEINS; TIME FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 42949165421     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.12.005     Document Type: Article

References (34)

1. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
2. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., and Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 99 (1997) 2752-2761
3. Nagano H., Mitchell R.N., Taylor M.K., Hasegawa S., Tilney N.L., and Libby P. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 100 (1997) 550-557
4. Tellides G., Tereb D.A., Kirkiles-Smith N.C., Kim R.W., Wilson J.H., Schechner J.S., et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 403 (2000) 207-211
5. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 88-91
6. Ushio S., Namba M., Okura T., Hattori K., Nukada Y., Akita K., et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156 (1996) 4274-4279
7. Udagawa N., Horwood N.J., Elliott J., Mackay A., Owens J., Okamura H., et al. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 185 (1997) 1005-1012
8. Olee T., Hashimoto S., Quach J., and Lotz M. IL18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 162 (1999) 1096-1100
9. Stoll S., Muller G., Kurimoto M., Saloga J., Tanimoto T., Yamauchi H., et al. Production of IL18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 159 (1997) 298-302
10. Mallat Z., Corbaz A., Scoazec A., Besnard S., Leseche G., Chvatchko Y., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104 (2001) 1598-1603
11. Li J.M., Zhang X., Nelson P.R., Odgren P.R., Nelson J.D., Vasiliu C., et al. Temporal evolution of gene expression in rat carotid artery following balloon angioplasty. J Cell Biochem 101 (2007) 399-410
12. Fantuzzi G., Puren A.J., Harding M.W., Livingston D.J., and Dinarello C.A. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. Blood 91 (1998) 2118-2125
13. Kohka H., Yoshino T., Iwagaki H., Sakuma I., Tanimoto T., Matsuo Y., et al. Interleukin-18/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol 64 (1998) 519-527
14. Nakanishi K., Yoshimoto T., Tsutsui H., and Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19 (2001) 423-474
15. Puren A.J., Fantuzzi G., Gu Y., Su M.S., and Dinarello C.A. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest 101 (1998) 711-721
16. Takeda K., Tsutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T., et al. Defective NK cell activity and Th1 response in IL18-deficient mice. Immunity 8 (1998) 383-390
17. Xu D., Chan W.L., Leung B.P., Hunter D., Schulz K., Carter R.W., et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 188 (1998) 1485-1492
18. Chandrasekar B., Mummidi S., Valente A.J., Patel D.N., Bailey S.R., Freeman G.L., et al. The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling. J Biol Chem 280 (2005) 26263-26277
19. Chandrasekar B., Mummidi S., Mahimainathan L., Patel D.N., Bailey S.R., Imam S.Z., et al. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J Biol Chem 281 (2006) 15099-15109
20. Kim S.H., Eisenstein M., Reznikov L., Fantuzzi G., Novick D., Rubinstein M., et al. Structural requirements of six naturally occurring isoforms of the IL18 binding protein to inhibit IL18. Proc Natl Acad Sci U S A 97 (2000) 1190-1195
21. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., and Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10 (1999) 127-136
22. Mallat Z., Corbaz A., Scoazec A., Graber P., Alouani S., Esposito B., et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 89 (2001) E41-E45
23. Maffia P., Grassia G., Di Meglio P., Carnuccio R., Berrino L., Garside P., et al. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Circulation 114 (2006) 430-437
24. National Institutes of Health. Guide for the care and use of laboratory animals. Publication No. 86-23 (1996), National Academic Press, Washington, DC
25. Li J.M., Singh M.J., Itani M., Vasiliu C., Hendricks G., Baker S.P., et al. Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury. J Vasc Surg 39 (2004) 1074-1083
26. McLean R.A., Sanders W.L., and Stroup W.W. A unified approach to mixed linear models. Am Stat 45 (1991) 54-64
27. Daniel W.W. Applied nonparametric statistics. 2nd ed. (1990), Duxbury, Pacific Grove, CA
28. Hilbe J.M. Negative binomial regression. 1st ed. (2007), Cambridge University Press, Cambridge
29. The GLIMMIX procedure (2005), SAS Institute Inc, Cary, NC
30. Torigoe K., Ushio S., Okura T., Kobayashi S., Taniai M., Kunikata T., et al. Purification and characterization of the human interleukin-18 receptor. J Biol Chem 272 (1997) 25737-25742
31. Born T.L., Thomassen E., Bird T.A., and Sims J.E. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem 273 (1998) 29445-29450
32. Hoshino K., Tsutsui H., Kawai T., Takeda K., Nakanishi K., Takeda Y., et al. Cutting edge: generation of IL18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL18 binding receptor. J Immunol 162 (1999) 5041-5044
33. Gerdes N., Sukhova G.K., Libby P., Reynolds R.S., Young J.L., and Schonbeck U. Expression of interleukin (IL)-18 and functional IL18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 195 (2002) 245-257
34. Reznikov L.L., Kim S.H., Westcott J.Y., Frishman J., Fantuzzi G., Novick D., et al. IL18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma. Proc Natl Acad Sci U S A 97 (2000) 2174-2179